IP Library Granted Patent US 12,414,997
Granted Patent B2
US 12,414,997 · App. 17/047,279 · Granted Sep 16, 2025

Brush prodrugs and uses thereof

Inventors: Jeremiah A. Johnson (Boston, MA); Farrukh Vohidov (Arlington, MA)
Assignee: Massachusetts Institute of Technology
A61K47/59A61K31/138A61K31/167A61K31/282A61K31/404A61K31/44A61K31/475A61K31/502A61K31/519A61K31/573A61K38/212A61K47/545C07F15/0046C08G61/08C08G2261/136C08G2261/1426C08G2261/143C08G2261/1432C08G2261/418
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,414,997
App. No.
17/047,279
Granted
Sep 16, 2025
Kind
B2
Abstract

The present disclosure provides, in some aspects, macromonomers of Formula (I), and salts thereof; methods of preparing the macromonomers, and salts thereof; Brush prodrugs (polymers); methods of preparing the Brush prodrugs; compounds of Formula (II); conjugates of Formula (III), and salts thereof; pharmaceutical compositions comprising a Brush prodrug, or a conjugate or a salt thereof; kits comprising: a macromonomer or a salt thereof, a Brush prodrug, a compound, a conjugate or a salt thereof, or a pharmaceutical composition; methods of using the Brush prodrugs, or conjugates or salts thereof; and uses of the Brush prodrugs, and conjugates or salts thereof. These chemical entities may be useful in delivering pharmaceutical agents to a subject or cell.

Claims (128)

1. A macromonomer of Formula (I):

or a salt thereof, wherein:

each instance of R A is independently hydrogen, halogen, or substituted or unsubstituted, C 1-6 alkyl;

a is an integer from 1 to 20, inclusive;

each instance of —Y—Z— is

each instance of M is independently hydrogen or a pharmaceutical agent;

each instance of m is independently an integer from 1 to 10, inclusive;

each instance of L is independently substituted or unsubstituted, C 1-200 alkylene, substituted or unsubstituted, C 2-200 alkenylene, substituted or unsubstituted, C 2-200 alkynylene, substituted or unsubstituted, C 2-200 heteroalkylene, substituted or unsubstituted, C 2-200 heteroalkenylene, or substituted or unsubstituted, C 2-200 heteroalkynylene, wherein:

optionally one or more carbons in each instance of the substituted or unsubstituted, C 1-200 alkylene, substituted or unsubstituted, C 2-200 alkenylene, substituted or unsubstituted, C 2-200 alkynylene, substituted or unsubstituted, C 2-200 heteroalkylene, substituted or unsubstituted, C 2-200 heteroalkenylene, and substituted or unsubstituted, C 2-200 heteroalkynylene are independently replaced with substituted or unsubstituted carbocyclylene, substituted or unsubstituted heterocyclylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene; and

optionally one or more heteroatoms in each instance of the substituted or unsubstituted, C 2-200 heteroalkylene, substituted or unsubstituted, C 2-200 heteroalkenylene, and substituted or unsubstituted, C 2-200 heteroalkynylene are independently replaced with substituted or unsubstituted carbocyclylene, substituted or unsubstituted heterocyclylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene;

each instance of W is independently a single bond, —O—, —S—, or —NR E —;

each instance of R E is independently hydrogen, substituted or unsubstituted, C 1-6 alkyl, or a nitrogen protecting group;

each instance of W′ is independently —O—, —S—, or —NR J —;

each instance of R′ is independently hydrogen, substituted or unsubstituted, C 1-6 alkyl, or a nitrogen protecting group;

each instance of R K and R L is independently hydrogen, halogen, substituted or unsubstituted, C 1-6 alkyl, substituted or unsubstituted, C 2-6 alkenyl, substituted or unsubstituted, C 2-6 alkynyl, substituted or unsubstituted, 3- to 7-membered, monocyclic carbocyclyl, substituted or unsubstituted, 3- to 7-membered, monocyclic heterocyclyl, substituted or unsubstituted phenyl, substituted or unsubstituted, 5- or 6-membered, monocyclic heteroaryl, —OR a , —N(R a ) 2 , —SR a , —CN, —SCN, —C(═NR a )R a , —C(═NR a )OR a , —C(═NR a )N(R a ) 2 , —C(═O)R a , —C(═O)OR a , —C(═O)N(R a ) 2 , —NO 2 , —NR a C(═O)R a , —NR a C(═O)OR a , —NR a C(═O)N(R a ) 2 , —OC(═O)R a , —OC(═O)OR a , or —OC(═O)N(R a ) 2 ;

each instance of R a is independently hydrogen, substituted or unsubstituted, C 1-6 alkyl, substituted or unsubstituted, C 2-6 alkenyl, substituted or unsubstituted, C 2-6 alkynyl, substituted or unsubstituted, 3- to 7-membered, monocyclic carbocyclyl, substituted or unsubstituted, 3- to 7-membered, monocyclic heterocyclyl, substituted or unsubstituted phenyl, substituted or unsubstituted, 5- or 6-membered, monocyclic heteroaryl, an oxygen protecting group when attached to an oxygen atom, a sulfur protecting group when attached to a sulfur atom, or a nitrogen protecting group when attached to a nitrogen atom; or two instances of R a attached to the same nitrogen atom are joined to form substituted or unsubstituted, 3- to 7-membered, monocyclic heterocyclyl, or substituted or unsubstituted, 5- or 6-membered, monocyclic heteroaryl;

each instance of T is independently a single bond, substituted or unsubstituted, C 1-20 alkylene, substituted or unsubstituted, C 2-20 alkenylene, substituted or unsubstituted, C 2-20 alkynylene, substituted or unsubstituted, C 2-20 heteroalkylene, substituted or unsubstituted, C 2-20 heteroalkenylene, or substituted or unsubstituted, C 2-20 heteroalkynylene, wherein:

optionally one or more carbons in each instance of the substituted or unsubstituted, C 1-20 alkylene, substituted or unsubstituted, C 2-20 alkenylene, substituted or unsubstituted, C 2-20 alkynylene, substituted or unsubstituted, C 2-20 heteroalkylene, substituted or unsubstituted, C 2-20 heteroalkenylene, and substituted or unsubstituted, C 2-20 heteroalkynylene are independently replaced with substituted or unsubstituted carbocyclylene, substituted or unsubstituted heterocyclylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene; and

optionally one or more heteroatoms in each instance of the substituted or unsubstituted, C 2-20 heteroalkylene, substituted or unsubstituted, C 2-20 heteroalkenylene, and substituted or unsubstituted, C 2-20 heteroalkynylene are independently replaced with substituted or unsubstituted carbocyclylene, substituted or unsubstituted heterocyclylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene;

each instance of R B is independently hydrogen, halogen, or substituted or unsubstituted, C 1-6 alkyl;

each instance of b is independently an integer from 1 to 20, inclusive;

e is an integer from 1 to 10, inclusive; and

X is —OR C or —N(R D ) 2 , wherein:

R C is hydrogen, substituted or unsubstituted, C 1-1000 alkyl, substituted or unsubstituted, C 2-1000 alkenyl, substituted or unsubstituted, C 2-1000 alkynyl, substituted or unsubstituted, C 1-1000 heteroalkyl, substituted or unsubstituted, C 2-1000 heteroalkenyl, substituted or unsubstituted, C 2-1000 heteroalkynyl, an oxygen protecting group, or a leaving group; and

each instance of R D is independently hydrogen, substituted or unsubstituted, C 1-1000 alkyl, substituted or unsubstituted, C 2-1000 alkenyl, substituted or unsubstituted, C 2-1000 alkynyl, substituted or unsubstituted, C 1-1000 heteroalkyl, substituted or unsubstituted, C 2-1000 heteroalkenyl, substituted or unsubstituted, C 2-1000 heteroalkynyl, or a nitrogen protecting group.

2. A method of preparing a macromonomer of claim 1 , or a salt thereof, comprising coupling a compound of the formula:

or a salt thereof, with a compound of the formula: HOR C or HN(R D ) 2 , or a salt thereof.

3. A polymer prepared by polymerizing one or more types of macromonomers of claim 1 , or a salt thereof, in the presence of a metathesis catalyst.

4. A method of preparing a polymer of claim 3 comprising polymerizing a macromonomer of Formula (I):

or a salt thereof, in the presence of a metathesis catalyst, wherein:

each instance of R A is independently hydrogen, halogen, or substituted or unsubstituted, C 1-6 alkyl;

a is an integer from 1 to 20, inclusive;

each instance of —Y—Z— is

each instance of M is independently hydrogen or a pharmaceutical agent;

each instance of m is independently an integer from 1 to 10, inclusive;

each instance of L is independently substituted or unsubstituted, C 1-200 alkylene, substituted or unsubstituted, C 2-200 alkenylene, substituted or unsubstituted, C 2-200 alkynylene, substituted or unsubstituted, C 2-200 heteroalkylene, substituted or unsubstituted, C 2-200 heteroalkenylene, or substituted or unsubstituted, C 2-200 heteroalkynylene, wherein:

optionally one or more carbons in each instance of the substituted or unsubstituted, C 1-200 alkylene, substituted or unsubstituted, C 2-200 alkenylene, substituted or unsubstituted, C 2-200 alkynylene, substituted or unsubstituted, C 2-200 heteroalkylene, substituted or unsubstituted, C 2-200 heteroalkenylene, and substituted or unsubstituted, C 2-200 heteroalkynylene are independently replaced with substituted or unsubstituted carbocyclylene, substituted or unsubstituted heterocyclylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene; and

optionally one or more heteroatoms in each instance of the substituted or unsubstituted, C 2-200 heteroalkylene, substituted or unsubstituted, C 2-200 heteroalkenylene, and substituted or unsubstituted, C 2-200 heteroalkynylene are independently replaced with substituted or unsubstituted carbocyclylene, substituted or unsubstituted heterocyclylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene;

each instance of W is independently a single bond, —O—, —S—, or —NR E —;

each instance of R E is independently hydrogen, substituted or unsubstituted, C 1-6 alkyl, or a nitrogen protecting group;

each instance of W′ is independently —O—, —S—, or —NR J —;

each instance of R′ is independently hydrogen, substituted or unsubstituted, C 1-6 alkyl, or a nitrogen protecting group;

each instance of R K and R L is independently hydrogen, halogen, substituted or unsubstituted, C 1-6 alkyl, substituted or unsubstituted, C 2-6 alkenyl, substituted or unsubstituted, C 2-6 alkynyl, substituted or unsubstituted, 3- to 7-membered, monocyclic carbocyclyl, substituted or unsubstituted, 3- to 7-membered, monocyclic heterocyclyl, substituted or unsubstituted phenyl, substituted or unsubstituted, 5- or 6-membered, monocyclic heteroaryl, —OR a , —N(R a ) 2 , —SR a , —CN, —SCN, —C(═NR a )R a , —C(═NR a )OR a , —C(═NR a )N(R a ) 2 , —C(═O)R a , —C(═O)OR a , —C(═O)N(R a ) 2 , —NO 2 , —NR a C(═O)R a , —NR a C(═O)OR a , —NR a C(═O)N(R a ) 2 , —OC(═O)R a , —OC(═O)OR a , or —OC(═O)N(R a ) 2 ;

each instance of R a is independently hydrogen, substituted or unsubstituted, C 1-6 alkyl, substituted or unsubstituted, C 2-6 alkenyl, substituted or unsubstituted, C 2-6 alkynyl, substituted or unsubstituted, 3- to 7-membered, monocyclic carbocyclyl, substituted or unsubstituted, 3- to 7-membered, monocyclic heterocyclyl, substituted or unsubstituted phenyl, substituted or unsubstituted, 5- or 6-membered, monocyclic heteroaryl, an oxygen protecting group when attached to an oxygen atom, a sulfur protecting group when attached to a sulfur atom, or a nitrogen protecting group when attached to a nitrogen atom; or two instances of R a attached to the same nitrogen atom are joined to form substituted or unsubstituted, 3- to 7-membered, monocyclic heterocyclyl, or substituted or unsubstituted, 5- or 6-membered, monocyclic heteroaryl;

each instance of T is independently a single bond, substituted or unsubstituted, C 1-20 alkylene, substituted or unsubstituted, C 2-20 alkenylene, substituted or unsubstituted, C 2-20 alkynylene, substituted or unsubstituted, C 2-20 heteroalkylene, substituted or unsubstituted, C 2-20 heteroalkenylene, or substituted or unsubstituted, C 2-20 heteroalkynylene, wherein:

optionally one or more carbons in each instance of the substituted or unsubstituted, C 1-20 alkylene, substituted or unsubstituted, C 2-20 alkenylene, substituted or unsubstituted, C 2-20 alkynylene, substituted or unsubstituted, C 2-20 heteroalkylene, substituted or unsubstituted, C 2-20 heteroalkenylene, and substituted or unsubstituted, C 2-20 heteroalkynylene are independently replaced with substituted or unsubstituted carbocyclylene, substituted or unsubstituted heterocyclylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene; and

optionally one or more heteroatoms in each instance of the substituted or unsubstituted, C 2-20 heteroalkylene, substituted or unsubstituted, C 2-20 heteroalkenylene, and substituted or unsubstituted, C 2-20 heteroalkynylene are independently replaced with substituted or unsubstituted carbocyclylene, substituted or unsubstituted heterocyclylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene;

each instance of R B is independently hydrogen, halogen, or substituted or unsubstituted, C 1-6 alkyl;

each instance of b is independently an integer from 1 to 20, inclusive;

e is an integer from 1 to 10, inclusive; and

X is —OR C or —N(R D ) 2 , wherein:

R C is hydrogen, substituted or unsubstituted, C 1-1000 alkyl, substituted or unsubstituted, C 2-1000 alkenyl, substituted or unsubstituted, C 2-1000 alkynyl, substituted or unsubstituted, C 1-1000 heteroalkyl, substituted or unsubstituted, C 2-1000 heteroalkenyl, substituted or unsubstituted, C 2-1000 heteroalkynyl, an oxygen protecting group, or a leaving group; and

each instance of R D is independently hydrogen, substituted or unsubstituted, C 1-1000 alkyl, substituted or unsubstituted, C 2-1000 alkenyl, substituted or unsubstituted, C 2-1000 alkynyl, substituted or unsubstituted, C 1-1000 heteroalkyl, substituted or unsubstituted, C 2-1000 heteroalkenyl, substituted or unsubstituted, C 2-1000 heteroalkynyl, or a nitrogen protecting group.

5. A method of preparing a polymer of claim 3 comprising polymerizing a first macromonomer of Formula (I):

or a salt thereof, and a second macromonomer of Formula (I), or a salt thereof, in the presence of a metathesis catalyst, wherein at least one instance of M of the first macromonomer is different from at least one instance of M of the second macromonomer, and wherein:

each instance of R A is independently hydrogen, halogen, or substituted or unsubstituted, C 1-6 alkyl;

a is an integer from 1 to 20, inclusive;

each instance of —Y—Z— is

each instance of M is independently hydrogen or a pharmaceutical agent;

each instance of m is independently an integer from 1 to 10, inclusive;

each instance of L is independently substituted or unsubstituted, C 1-200 alkylene, substituted or unsubstituted, C 2-200 alkenylene, substituted or unsubstituted, C 2-200 alkynylene, substituted or unsubstituted, C 2-200 heteroalkylene, substituted or unsubstituted, C 2-200 heteroalkenylene, or substituted or unsubstituted, C 2-200 heteroalkynylene, wherein:

optionally one or more carbons in each instance of the substituted or unsubstituted, C 1-200 alkylene, substituted or unsubstituted, C 2-200 alkenylene, substituted or unsubstituted, C 2-200 alkynylene, substituted or unsubstituted, C 2-200 heteroalkylene, substituted or unsubstituted, C 2-200 heteroalkenylene, and substituted or unsubstituted, C 2-200 heteroalkynylene are independently replaced with substituted or unsubstituted carbocyclylene, substituted or unsubstituted heterocyclylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene; and

optionally one or more heteroatoms in each instance of the substituted or unsubstituted, C 2-200 heteroalkylene, substituted or unsubstituted, C 2-200 heteroalkenylene, and substituted or unsubstituted, C 2-200 heteroalkynylene are independently replaced with substituted or unsubstituted carbocyclylene, substituted or unsubstituted heterocyclylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene;

each instance of W is independently a single bond, —O—, —S—, or —NR E —;

each instance of R E is independently hydrogen, substituted or unsubstituted, C 1-6 alkyl, or a nitrogen protecting group;

each instance of W′ is independently —O—, —S—, or —NR J —;

each instance of R J is independently hydrogen, substituted or unsubstituted, C 1-6 alkyl, or a nitrogen protecting group;

each instance of R K and R L is independently hydrogen, halogen, substituted or unsubstituted, C 1-6 alkyl, substituted or unsubstituted, C 2-6 alkenyl, substituted or unsubstituted, C 2-6 alkynyl, substituted or unsubstituted, 3- to 7-membered, monocyclic carbocyclyl, substituted or unsubstituted, 3- to 7-membered, monocyclic heterocyclyl, substituted or unsubstituted phenyl, substituted or unsubstituted, 5- or 6-membered, monocyclic heteroaryl, —OR a , —N(R a ) 2 , —SR a , —CN, —SCN, —C(═NR a )R a , —C(═NR a )OR a , —C(═NR a )N(R a ) 2 , —C(═O)R a , —C(═O)OR a , —C(═O)N(R a ) 2 , —NO 2 , —NR a C(═O)R a , —NR a C(═O)OR a , —NR a C(═O)N(R a ) 2 , —OC(═O)R a , —OC(═O)OR a , or —OC(═O)N(R a ) 2 ;

each instance of R a is independently hydrogen, substituted or unsubstituted, C 1-6 alkyl, substituted or unsubstituted, C 2-6 alkenyl, substituted or unsubstituted, C 2-6 alkynyl, substituted or unsubstituted, 3- to 7-membered, monocyclic carbocyclyl, substituted or unsubstituted, 3- to 7-membered, monocyclic heterocyclyl, substituted or unsubstituted phenyl, substituted or unsubstituted, 5- or 6-membered, monocyclic heteroaryl, an oxygen protecting group when attached to an oxygen atom, a sulfur protecting group when attached to a sulfur atom, or a nitrogen protecting group when attached to a nitrogen atom; or two instances of R a attached to the same nitrogen atom are joined to form substituted or unsubstituted, 3- to 7-membered, monocyclic heterocyclyl, or substituted or unsubstituted, 5- or 6-membered, monocyclic heteroaryl;

each instance of T is independently a single bond, substituted or unsubstituted, C 1-20 alkylene, substituted or unsubstituted, C 2-20 alkenylene, substituted or unsubstituted, C 2-20 alkynylene, substituted or unsubstituted, C 2-20 heteroalkylene, substituted or unsubstituted, C 2-20 heteroalkenylene, or substituted or unsubstituted, C 2-20 heteroalkynylene, wherein:

optionally one or more carbons in each instance of the substituted or unsubstituted, C 1-20 alkylene, substituted or unsubstituted, C 2-20 alkenylene, substituted or unsubstituted, C 2-20 alkynylene, substituted or unsubstituted, C 2-20 heteroalkylene, substituted or unsubstituted, C 2-20 heteroalkenylene, and substituted or unsubstituted, C 2-20 heteroalkynylene are independently replaced with substituted or unsubstituted carbocyclylene, substituted or unsubstituted heterocyclylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene; and

optionally one or more heteroatoms in each instance of the substituted or unsubstituted, C 2-20 heteroalkylene, substituted or unsubstituted, C 2-20 heteroalkenylene, and substituted or unsubstituted, C 2-20 heteroalkynylene are independently replaced with substituted or unsubstituted carbocyclylene, substituted or unsubstituted heterocyclylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene;

each instance of R B is independently hydrogen, halogen, or substituted or unsubstituted, C 1-6 alkyl;

each instance of b is independently an integer from 1 to 20, inclusive;

e is an integer from 1 to 10, inclusive; and

X is —OR C or —N(R D ) 2 , wherein:

R C is hydrogen, substituted or unsubstituted, C 1-1000 alkyl, substituted or unsubstituted, C 2-1000 alkenyl, substituted or unsubstituted, C 2-1000 alkynyl, substituted or unsubstituted, C 1-1000 heteroalkyl, substituted or unsubstituted, C 2-1000 heteroalkenyl, substituted or unsubstituted, C 2-1000 heteroalkynyl, an oxygen protecting group, or a leaving group; and

each instance of R D is independently hydrogen, substituted or unsubstituted, C 1-1000 alkyl, substituted or unsubstituted, C 2-1000 alkenyl, substituted or unsubstituted, C 2-1000 alkynyl, substituted or unsubstituted, C 1-1000 heteroalkyl, substituted or unsubstituted, C 2-1000 heteroalkenyl, substituted or unsubstituted, C 2-1000 heteroalkynyl, or a nitrogen protecting group.

6. A pharmaceutical composition comprising a polymer of claim 3 and optionally a pharmaceutically acceptable excipient.

7. A kit comprising:

a macromonomer of claim 1 , or a salt thereof; and

instructions for using the macromonomer, or a salt thereof.

8. A method of delivering a pharmaceutical agent to a subject in need thereof comprising administering to the subject in need thereof a polymer of claim 3 .

9. A method of delivering a pharmaceutical agent to a cell comprising contacting the cell with a polymer of claim 3 .

10. A method of treating a disease in a subject in need thereof comprising administering to or implanting in the subject in need thereof a therapeutically effective amount of:

a polymer of claim 3 ;

wherein at least one instance of M is a therapeutic agent.

11. A method of preventing a disease in a subject in need thereof comprising administering to or implanting in the subject in need thereof a prophylactically effective amount of:

a polymer of claim 3 ;

wherein at least one instance of M is a prophylactic agent.

12. A method of diagnosing a disease in a subject comprising administering to or implanting in the subject a diagnostically effective amount of:

a polymer of claim 3 ;

wherein at least one instance of M is a diagnostic agent.

13. A kit comprising:

a polymer of claim 3 ; and

instructions for using the polymer.

14. The polymer of claim 3 , wherein each instance of R A and R B is hydrogen.

15. The polymer of claim 14 , wherein each instance of —Y—Z— is

16. The polymer of claim 15 , wherein each instance of L is independently substituted or unsubstituted, C 1-200 alkylene or substituted or unsubstituted, C 2-200 heteroalkylene, wherein one or more carbons in the C 1-200 alkylene or C 2-200 heteroalkylene are replaced with substituted or unsubstituted heteroarylene.

17. The polymer of claim 15 , wherein each instance of L is substituted or unsubstituted, C 3-30 alkylene.

18. The polymer of claim 16 , wherein each instance of W is a single bond.

19. The polymer of claim 18 , wherein each instance of R K is hydrogen, and each instance of R L is hydrogen.

20. The polymer of claim 19 , wherein each instance of T is independently a single bond, substituted or unsubstituted, C 1-20 alkylene, or substituted or unsubstituted, C 2-20 heteroalkylene, and each instance of M is a pharmaceutical agent.

21. The polymer of claim 20 , wherein X is —N(R D ) 2 .

22. The polymer of claim 21 , wherein each instance of R D is independently hydrogen or substituted or unsubstituted, C 1-1000 heteroalkyl, provided that at least one instance of R D is substituted or unsubstituted, C 50-1000 heteroalkyl.

23. The polymer of claim 3 , wherein the macromonomer is of the formula:

or a salt thereof.

24. The polymer of claim 3 , wherein the macromonomer is of the formula:

or a salt thereof.

25. The macromonomer of claim 1 , or a salt thereof, wherein the macromonomer is of the formula:

26. The macromonomer of claim 1 , or a salt thereof, wherein the macromonomer is of the formula:

27. The polymer of claim 21 , wherein X is

n is an integer from 40 to 100, inclusive; and R F is hydrogen or unsubstituted C 1-6 alkyl.

28. The polymer of claim 27 , wherein each instance of M is an anti-cancer agent.

29. The polymer of claim 28 , wherein each instance of m is independently 1, 2, or 3, and e is 1, 2, or 3.

30. The macromonomer of claim 1 , or a salt thereof, wherein each instance of R A and R B is hydrogen.

31. The macromonomer of claim 30 , or a salt thereof, wherein each instance of —Y—Z— is

32. The macromonomer of claim 31 , or a salt thereof, wherein each instance of L is independently substituted or unsubstituted, C 1-200 alkylene or substituted or unsubstituted, C 2-200 heteroalkylene, wherein one or more carbons in the C 1-200 alkylene or C 2-200 heteroalkylene are replaced with substituted or unsubstituted heteroarylene.

33. The macromonomer of claim 31 , or a salt thereof, wherein each instance of L is substituted or unsubstituted, C 3-30 alkylene.

34. The macromonomer of claim 32 , or a salt thereof, wherein each instance of W is a single bond.

35. The macromonomer of claim 34 , or a salt thereof, wherein each instance of R K is hydrogen, and each instance of R L is hydrogen.

36. The macromonomer of claim 35 , or a salt thereof, wherein each instance of T is independently a single bond, substituted or unsubstituted, C 1-20 alkylene, or substituted or unsubstituted, C 2-20 heteroalkylene, and each instance of M is a pharmaceutical agent.

37. The macromonomer of claim 36 , or a salt thereof, wherein X is —N(R D ) 2 .

38. The macromonomer of claim 37 , or a salt thereof, wherein each instance of R D is independently hydrogen or substituted or unsubstituted, C 1-1000 heteroalkyl, provided that at least one instance of R D is substituted or unsubstituted, C 50-1000 heteroalkyl.

39. The macromonomer of claim 37 , or a salt thereof, wherein X is

n is an integer from 40 to 100, inclusive; and R F is hydrogen or unsubstituted C 1-6 alkyl.

40. The macromonomer of claim 39 , or a salt thereof, wherein each instance of M is an anti-cancer agent.

41. The macromonomer of claim 40 , or a salt thereof, wherein each instance of m is independently 1, 2, or 3, and e is 1, 2, or 3.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2021
From: JOHNSON, JEREMIAH A.; VOHIDOV, FARRUKH
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 057425/0056 →
Continuity (3)
Provisional Application 62657715 · Apr 13, 2018
Related Publication 20210386861A1 · Dec 16, 2021
Related Publication 20220370628A9 · Nov 24, 2022
References Cited (400)
US 3256308A · Pawloski et al. · 1966 [cited by applicant]
US 3337598A · Pawloski et al. · 1967 [cited by applicant]
US 4359425A · Totani et al. · 1982 [cited by applicant]
US 4510136A · Moberg et al. · 1985 [cited by applicant]
US 5811515A · Grubbs et al. · 1998 [cited by applicant]
US 6812238B1 · Fukuda et al. · 2004 [cited by applicant]
US 7183059B2 · Verdine et al. · 2007 [cited by applicant]
US 8067505B2 · Harris et al. · 2011 [cited by applicant]
US 8968920B2 · Lee et al. · 2015 [cited by applicant]
US 9381253B2 · Johnson et al. · 2016 [cited by applicant]
US 9447129B2 · Johnson et al. · 2016 [cited by applicant]
US 9822216B2 · Mahanthappa et al. · 2017 [cited by applicant]
US 10023536B2 · Johnson et al. · 2018 [cited by applicant]
US 10105449B2 · Johnson et al. · 2018 [cited by applicant]
US 10153513B2 · Grubbs et al. · 2018 [cited by applicant]
US 10159749B2 · Johnson et al. · 2018 [cited by applicant]
US 10683387B2 · Johnson et al. · 2020 [cited by applicant]
US 10716858B2 · Johnson et al. · 2020 [cited by applicant]
US 10792373B2 · Johnson et al. · 2020 [cited by applicant]
US 10793683B2 · Johnson et al. · 2020 [cited by applicant]
US 10799594B2 · Johnson et al. · 2020 [cited by applicant]
US 10961338B2 · Johnson et al. · 2021 [cited by applicant]
US 10973847B2 · Johnson et al. · 2021 [cited by applicant]
US 10988491B2 · Johnson et al. · 2021 [cited by applicant]
US 11338038B2 · Johnson et al. · 2022 [cited by applicant]
US 11752221B2 · Johnson et al. · 2023 [cited by applicant]
US 11827744B2 · Johnson et al. · 2023 [cited by applicant]
US 11897905B2 · Johnson et al. · 2024 [cited by applicant]
US 12084415B2 · Johnson et al. · 2024 [cited by applicant]
US 20020183473A1 · Matyjaszewski et al. · 2002 [cited by applicant]
US 20020198328A1 · L'Alloret · 2002 [cited by applicant]
US 20030004364A1 · Yaghi et al. · 2003 [cited by applicant]
US 20030065023A1 · Swindell et al. · 2003 [cited by applicant]
US 20050109976A1 · Fuchs et al. · 2005 [cited by applicant]
US 20080063937A1 · Lee et al. · 2008 [cited by applicant]
US 20080248126A1 · Cheng · 2008 [cited by examiner]
US 20110166128A1 · Remenar et al. · 2011 [cited by applicant]
US 20110243848A1 · Appel et al. · 2011 [cited by applicant]
US 20110300219A1 · Lippard et al. · 2011 [cited by applicant]
US 20130296491A1 · Xia et al. · 2013 [cited by applicant]
US 20130324666A1 · Yan et al. · 2013 [cited by applicant]
US 20140024137A1 · Arya et al. · 2014 [cited by applicant]
US 20140142249A1 · Cho et al. · 2014 [cited by applicant]
US 20140308234A1 · Johnson et al. · 2014 [cited by applicant]
US 20150225438A1 · Johnson et al. · 2015 [cited by applicant]
US 20150291562A1 · Crew et al. · 2015 [cited by applicant]
US 20160024246A1 · Mahanthappa et al. · 2016 [cited by applicant]
US 20160289392A1 · Grubbs et al. · 2016 [cited by applicant]
US 20160296631A1 · Johnson et al. · 2016 [cited by applicant]
US 20160361702A1 · Cohen et al. · 2016 [cited by applicant]
US 20170000909A1 · Gianneschi et al. · 2017 [cited by applicant]
US 20170073311A1 · Johnson et al. · 2017 [cited by applicant]
US 20170348431A1 · Johnson et al. · 2017 [cited by applicant]
US 20180030213A1 · Johnson et al. · 2018 [cited by applicant]
US 20180036415A9 · Johnson et al. · 2018 [cited by applicant]
US 20180094099A1 · Johnson et al. · 2018 [cited by applicant]
US 20180258233A9 · Johnson et al. · 2018 [cited by applicant]
US 20180312634A1 · Chung et al. · 2018 [cited by applicant]
US 20190030067A1 · Johnson et al. · 2019 [cited by applicant]
US 20190038751A1 · Johnson et al. · 2019 [cited by applicant]
US 20190038782A1 · Johnson et al. · 2019 [cited by applicant]
US 20190054187A1 · Johnson et al. · 2019 [cited by applicant]
US 20190192672A1 · Johnson et al. · 2019 [cited by applicant]
US 20200055879A1 · Johnson et al. · 2020 [cited by applicant]
US 20200123297A1 · Johnson et al. · 2020 [cited by applicant]
US 20200239626A1 · Miyake et al. · 2020 [cited by applicant]
US 20200261596A1 · Ali et al. · 2020 [cited by applicant]
US 20200362095A1 · Johnson et al. · 2020 [cited by applicant]
US 20200369685A1 · Johnson et al. · 2020 [cited by applicant]
US 20210023224A1 · Johnson et al. · 2021 [cited by applicant]
US 20210113701A1 · Johnson et al. · 2021 [cited by applicant]
US 20210147598A1 · Johnson et al. · 2021 [cited by applicant]
US 20210220391A1 · Johnson et al. · 2021 [cited by applicant]
US 20210284664A1 · Johnson et al. · 2021 [cited by applicant]
US 20210317143A9 · Johnson et al. · 2021 [cited by applicant]
US 20210386861A1 · Johnson et al. · 2021 [cited by applicant]
US 20230068959A1 · Johnson et al. · 2023 [cited by applicant]
US 20230192610A1 · Johnson et al. · 2023 [cited by applicant]
US 20240294555A1 · Johnson et al. · 2024 [cited by applicant]
CN 101412792A · 2009 [cited by applicant]
CN 103037903A · 2013 [cited by applicant]
CN 103819486A · 2014 [cited by applicant]
CN 106132970A · 2016 [cited by applicant]
CN 106715437A · 2017 [cited by applicant]
CN 108727581A · 2018 [cited by applicant]
DE 2263509A1 · 1974 [cited by applicant]
EP 3315126A1 · 2018 [cited by applicant]
EP 3584245A1 · 2019 [cited by applicant]
JP H05112739A · 1993 [cited by applicant]
JP 2004517932A · 2004 [cited by applicant]
JP 2013526549A · 2013 [cited by applicant]
JP 2022549915A · 2022 [cited by applicant]
KR 20120113694A · 2012 [cited by applicant]
WO WO2001032652A2 · 2001 [cited by applicant]
WO WO2006052733A1 · 2006 [cited by applicant]
WO WO2010047765A1 · 2010 [cited by applicant]
WO WO2011084846A1 · 2011 [cited by applicant]
WO WO2013010676A2 · 2013 [cited by applicant]
WO WO2013116200A1 · 2013 [cited by applicant]
WO WO2013169739A1 · 2013 [cited by applicant]
WO WO2014004884A1 · 2014 [cited by applicant]
WO WO2014169073A1 · 2014 [cited by applicant]
WO WO2015117136A1 · 2015 [cited by applicant]
WO WO2016023036A1 · 2016 [cited by applicant]
WO WO2016172386A1 · 2016 [cited by applicant]
WO WO2017180834A1 · 2017 [cited by applicant]
WO WO2017205392A1 · 2017 [cited by applicant]
WO WO2018073790A1 · 2018 [cited by applicant]
WO WO2018106738A1 · 2018 [cited by applicant]
WO WO2018149359A1 · 2018 [cited by applicant]
WO WO2019006426A2 · 2019 [cited by applicant]
WO WO2019200367A1 · 2019 [cited by applicant]
WO WO2019201123A1 · 2019 [cited by applicant]
Barnes, Jonathan et al “Using an RNAi Signature Assay to Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity” Sep. 14, 2016 Journal of the American Chemi… [cited by examiner]
International Search Report and Written Opinion for PCT/US2019/046872, mailed on Oct. 29, 2019. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2019/046872, mailed on Mar. 4, 2021. [cited by applicant]
International Search Report and Written Opinion for PCT/US2020/023836, mailed on Jul. 7, 2020. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2020/023836, mailed on Dec. 2, 2021. [cited by applicant]
Invitation to Pay Additional Fees for PCT/US2020/059827 mailed Feb. 4, 2021. [cited by applicant]
International Search Report and Written Opinion for PCT/US2020/059827 mailed Mar. 15, 2021. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2020/059827 mailed Jul. 21, 2022. [cited by applicant]
Invitation to Pay Additional Fees for PCT/US2020/055862, mailed on Feb. 12, 2021. [cited by applicant]
International Search Report and Written Opinion for PCT/US2020/055862 mailed May 6, 2021. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2020/055862 mailed Apr. 28, 2022. [cited by applicant]
International Search Report and Written Opinion for PCT/US2022/047333 mailed Jan. 25, 2023. [cited by applicant]
[No Author Listed], CAS Abstract of S. Masuoka et al., JP 05112739 (1993). CAS Registry File RN 150076-39-4. 2023. 7 pages. [cited by applicant]
Baslé et al., Protein chemical modification on endogenous amino acids. Chem Biol. Mar. 26, 2010;17(3):213-27. doi: 10.1016/j.chembiol.2010.02.008. [cited by applicant]
Beck et al., Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. May 2017;16(5):315-337. doi: 10.1038/nrd.2016.268. Epub Mar. 17, 2017. [cited by applicant]
Blencowe et al., Ring-opening metathesis polymerization with the second generation Hoveyda-Grubbs catalyst: an efficient approach toward high-purity functionalized macrocyclic oligo(cyclooctene)s. J Am Chem Soc. Apr. 17… [cited by applicant]
Borke et al., Poly(glyceryl glycerol): A multi-functional hydrophilic polymer for labeling with boronic acids. Polym Chem. Jun. 1, 2017;55(11):1822-30. doi: 10.1002/pola.28497. [cited by applicant]
Burke et al., Development of Novel Quaternary Ammonium Linkers for Antibody-Drug Conjugates. Mol Cancer Ther. May 2016;15(5):938-45. doi: 10.1158/1535-7163.MCT-16-0038. Epub Mar. 4, 2016. [cited by applicant]
Cannon, J.G., Analog Design. In: Burger's Medicinal Chemistry and Drug Discovery, Fifth Edition, vol. I: Principles and Practice. 1995. Burger, Ed. Wiley Interscience. Chapter 19:783-802. [cited by applicant]
Clark et al., Dynamically Restructuring Hydrogel Networks Formed with Reversible Covalent Crosslinks. Advanced Materials. 2007; 19:2503-2507. 10.1002/adma.200602649. [cited by applicant]
Collins et al., Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway. Biochem J. Mar. 15, 2017;474(7):1127-1147. doi: 10.1042/BCJ20160762. [cited by applicant]
Corey et al., Diisopropylsilyl ditriflate and di-tert-butysilyl ditriflate: new reagents for the protection of diols. Tetrahedron Letters. 1982;23(47):4871-4874. [cited by applicant]
Dennler et al., Antibody Conjugates: From Heterogeneous Populations to Defined Reagents. Antibodies. Aug. 3, 2015;4(3):197-224. doi: 10.3390/antib4030197. [cited by applicant]
Dutta et al., Dilute solution structure of bottlebrush polymers. Soft Matter. Apr. 3, 2019;15(14):2928-2941. doi: 10.1039/c9sm00033j. [cited by applicant]
Ekladious et al., Polymer-drug conjugate therapeutics: advances, insights and prospects. Nat Rev Drug Discov. Apr. 2019;18(4):273-294. doi: 10.1038/s41573-018-0005-0. [cited by applicant]
Evans, R.A., The Rise of Azide-Alkyne 1,3-Dipolar ‘Click’ Cycloaddition and its Application to Polymer Science and Surface Modification. Aust J Chem. Jun. 18, 2007;60(6):384-95. doi: 10.1071/CH06457. [cited by applicant]
Fiers et al., Orthogonal Synthesis of Xeno Nucleic Acids. Chemistry. Dec. 12, 2016;22(50):17945-17948. doi: 10.1002/chem.201604386. Epub Nov. 3, 2016. [cited by applicant]
Foster et al., Getting into Shape: Reflections on a New Generation of Cylindrical Nanostructures' Self-Assembly Using Polymer Building Blocks. J Am Chem Soc. Feb. 20, 2019;141(7):2742-2753. doi: 10.1021/jacs.8b08648. Ep… [cited by applicant]
Fu et al., Relay Conjugation of Living Metathesis Polymers. J Am Chem Soc. Sep. 26, 2018;140(38):12181-12188. doi: 10.1021/jacs.8b07315. Epub Sep. 11, 2018. [cited by applicant]
Furstner et al., Alkyne metathesis: development of a novel molybdenum-based catalyst system and its application to the total synthesis of epothilone A and C. Chem Eur J. Dec. 17, 2001;7(24):5299-317. doi: 10.1002/1521-3… [cited by applicant]
Furstner et al., Mo[N(t-Bu)(Ar)] [cited by applicant]
Gallivan et al., A neutral, water-soluble olefin metathesis catalyst based on an N-heterocyclic carbene ligand. Tetrahedron Lett. Apr. 11, 2005;46(15):2577-80. doi: 10.1016/j.tetlet.2005.02.096. [cited by applicant]
Grubbs et al., Ring-Closing Metathesis and Related Processes in Organic Synthesis. Acc Chem Res. Nov. 1, 1995;28(11):446-52. doi: 10.1021/ar00059a002. [cited by applicant]
Gupta et al., Cell protective, ABC triblock polymer-based thermoresponsive hydrogels with ROS-triggered degradation and drug release. J Am Chem Soc. Oct. 22, 2014;136(42):14896-902. doi: 10.1021/ja507626y. Epub Oct. 7, … [cited by applicant]
Hamblett et al., Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate. Clin Cancer Res. Oct. 15, 2004;10(20):7063-70. doi: 10.1158/1078-0432.CCR-04-0789. [cited by applicant]
Hoye et al., Silicon tethered ring-closing metathesis reactions for self- and cross-coupling of alkenols. Tetrahedron Letters. Feb. 19, 1999;40(8):1429-1432. [cited by applicant]
Knall et al., Inverse electron demand Diels-Alder (iEDDA)-initiated conjugation: a (high) potential click chemistry scheme. Chem Soc Rev. Jun. 21, 2013;42(12):5131-42. doi: 10.1039/c3cs60049a. [cited by applicant]
Kodger, T., Mechanical Failure in Colloidal Gels. Dissertation. Harvard University. Dec. 2014. 255 pages. [cited by applicant]
Kumar et al., Multivalency in the recognition and antagonism of a HIV TAR RNA-TAT assembly using an aminoglycoside benzimidazole scaffold. Org Biomol Chem. Feb. 14, 2016;14(6):2052-6. doi: 10.1039/c5ob02016f. [cited by applicant]
Lambert et al., Ado-trastuzumab Emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer. J Med Chem. Aug. 28, 2014;57(16):6949-64. doi: 10.1021/jm500766w. Epub Jul. 10, 2014. [cited by applicant]
Li et al., Thermoresponsive PNIPAAM bottlebrush polymers with tailored side-chain length and end-group structure. Soft Matter. Mar. 28, 2014;10(12):2008-15. doi: 10.1039/c3sm52614c. [cited by applicant]
Luginbuhl et al., One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer. Nat Biomed Eng. 2017;1:0078. doi: 10.1038/s41551-017-… [cited by applicant]
Lyon et al., Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index. Nat Biotechnol. Jul. 2015;33(7):733-5. doi: 10.1038/nbt.3212. Epub Jun. 15, 2015. [cited by applicant]
Manyeruke et al., Synthesis and evaluation of 3-hydroxy-3-phenylpropanoate ester-AZT conjugates as potential dual-action HIV-1 Integrase and Reverse Transcriptase inhibitors. Bioorg Med Chem. Dec. 15, 2015;23(24):7521-8… [cited by applicant]
Nguyen et al., Scalable Synthesis of Multivalent Macromonomers for ROMP. ACS Macro Lett. Apr. 17, 2018;7(4):472-476. doi: 10.1021/acsmacrolett.8b00201. Epub Mar. 26, 2018. [cited by applicant]
Nishimura et al., Rhodium-Catalyzed Asymmetric Cycloisomerization of 1,6-Ene-ynamides. Adv Synth Catal. May 3, 2013;355(7):1374-82. doi: 10.1002/adsc.201300148. [cited by applicant]
Ohwada et al., Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole. Bioorg Med Chem Lett. Jan. 20, 2003;13(2):191-6. doi: 10.1016/s0960-894x(02)00892-2. [cited by applicant]
Panchamoorthy et al., Targeting the human MUC1-C oncoprotein with an antibody-drug conjugate. JCI Insight. Jun. 21, 2018;3(12):e99880. doi: 10.1172/jci.insight.99880. [cited by applicant]
Qi et al., A brush-polymer conjugate of exendin-4 reduces blood glucose for up to five days and eliminates poly(ethylene glycol) antigenicity. Nat Biomed Eng. 2016;1:0002. doi: 10.1038/s41551-016-0002. Epub Nov. 28, 201… [cited by applicant]
Qiu et al., ROMP synthesis of benzaldehyde-containing amphiphilic block polynorbornenes used to conjugate drugs for pH-responsive release. React Func Polym. Jul. 2018;128:1-15. doi: 10.1016/j.reactfunctpolym.2018.03.010. [cited by applicant]
Sakamoto et al., Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Proc Natl Acad Sci U S A. Jul. 17, 2001;98(15):8554-9. doi: 10.1073/pnas.141230798. … [cited by applicant]
Schrock et al., Tungsten(VI) neopentylidyne complexes. Organometallics. Dec. 1, 1982;1(12):1645-51. doi: 10.1021/om00072a018. [cited by applicant]
Shibuya et al., Mikto-Brush-Arm Star Polymers via Cross-Linking of Dissimilar Bottlebrushes: Synthesis and Solution Morphologies. ACS Macro Lett. Sep. 19, 2017;6(9):963-968. doi: 10.1021/acsmacrolett.7b00529. Epub Aug. … [cited by applicant]
Shieh et al., Tailored silyl ether monomers enable backbone-degradable polynorbornene-based linear, bottlebrush and star copolymers through ROMP. Nat Chem. Dec. 2019;11(12):1124-1132. doi: 10.1038/s41557-019-0352-4. Epu… [cited by applicant]
Smith et al., Modular synthesis of biologically active phosphatidic acid probes using click chemistry. Mol Biosyst. Sep. 2009;5(9):962-72. doi: 10.1039/b901420a. Epub May 7, 2009. [cited by applicant]
Sowers et al., Redox-responsive branched-bottlebrush polymers for in vivo MRI and fluorescence imaging. Nat Commun. Nov. 18, 2014;5:5460. doi: 10.1038/ncomms6460. [cited by applicant]
Staben et al., Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates. Nat Chem. Dec. 2016;8(12):1112-1119. doi: 10.1038/nchem.2635. Epub Oct. 17, 2016. [cited by applicant]
Tian et al., Selective esterase-ester pair for targeting small molecules with cellular specificity. Proc Natl Acad Sci U S A. Mar. 27, 2012;109(13):4756-61. doi: 10.1073/pnas.1111943109. Epub Mar. 12, 2012. [cited by applicant]
Tinworth et al., Small molecule-mediated protein knockdown as a new approach to drug discovery. Med Chem Commun. Jul. 26, 2016;7:2206-16. doi: 10.1039/C6MD00347H. [cited by applicant]
Tolcher et al., Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer. J Clin Oncol. Feb. 1999;17(2):478-84. doi: 10.1200/JCO.1999.17.2.478. [cited by applicant]
Trail et al., Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates. Science. Jul. 9, 1993;261(5118):212-5. doi: 10.1126/science.8327892. Erratum in: Science Feb. 25, 1994;263(5150):1076. [cited by applicant]
Tu et al., Recent advances towards applications of molecular bottlebrushes and their conjugates. Curr Opin Solid State Mater Sci. Feb. 2019;23(1):50-61. doi: 10.1016/j.cossms.2019.01.003. [cited by applicant]
Venkatesh et al., Role of the development scientist in compound lead selection and optimization. J Pharm Sci. Feb. 2000;89(2):145-54. doi: 10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6. [cited by applicant]
Vohidov et al., Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic Toxicities. J Am Chem Soc. Mar. 31, 2021;143(12):4714-4724. doi: 10.1021/jacs.1c00312. Epub Mar. 19, 2021. Autho… [cited by applicant]
Xiao et al., Precision glycocalyx editing as a strategy for cancer immunotherapy. Proc Natl Acad Sci U S A. Sep. 13, 2016;113(37):10304-9. doi: 10.1073/pnas.1608069113. Epub Aug. 22, 2016. [cited by applicant]
Xu et al., Site-specific labeling of an anti-MUC1 antibody: probing the effects of conjugation and linker chemistry on the internalization process. RSC Adv. Jan. 15, 2019;9(4):1909-1917. doi: 10.1039/c8ra09902b. [cited by applicant]
Yan et al., The relationship among pKa, pH, and binding constants in the interactions between boronic acids and diols-it is not as simple as it appears. Tetrahedron. Nov. 29, 2004;60(49):11205-11209. [cited by applicant]
Yurkovetskiy et al., A Polymer-Based Antibody-Vinca Drug Conjugate Platform: Characterization and Preclinical Efficacy. Cancer Res. Aug. 15, 2015;75(16):3365-72. doi: 10.1158/0008-5472.CAN-15-0129. Epub Jun. 25, 2015. [cited by applicant]
Yurkovetskiy et al., Fully degradable hydrophilic polyals for protein modification. Biomacromolecules. Sep.-Oct. 2005;6(5):2648-58. doi: 10.1021/bm049210k. [cited by applicant]
Zhang et al., Convergent Synthesis of Branched Metathesis Polymers with Enyne Reagents. Macromolecules. Sep. 28, 2021;54(18):8435-8442. doi: 10.1021/acs.macromol.1c01051. Epub Sep. 8, 2021. [cited by applicant]
Zhang et al., Practical Synthesis of Functional Metathesis Initiators Using Enynes. Macromol. Aug. 16, 2018;51(16):6497-503. doi: 10.1021/acs.macromol.8b00866. [cited by applicant]
International Search Report and Written Opinion for PCT/US2019/027414, mailed on Sep. 12, 2019. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2019/027414, mailed on Oct. 22, 2020. [cited by applicant]
Gao et al., Synthesis of Acid-Labile PEG and PEG-Doxorubicin-Conjugate Nanoparticles via Brush-First ROMP. ACS Macro Lett. Sep. 16, 2014;3(9):854-857. doi: 10.1021/mz5004097. Epub Aug. 13, 2014. PMID: 25243099; PMCID: P… [cited by applicant]
Extended European Search Report for EP 14782253.0, mailed Nov. 11, 2016. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2014/033554, mailed Oct. 22, 2015. [cited by applicant]
International Search Report and Written Opinion for PCT/US2014/033554, mailed Aug. 29, 2014. [cited by applicant]
International Search Report for PCT/US2017/036447, mailed Sep. 7, 2017. [cited by applicant]
International Preliminary Report on Patentability for Application No. PCT/US2017/036447 mailed Dec. 20, 2018. [cited by applicant]
International Search Report and Written Opinion for PCT/US2017/055145, mailed Jan. 23, 2018. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2017/055145, mailed Apr. 18, 2019. [cited by applicant]
International Search Report and Written Opinion for PCT/US2017/064784, mailed Mar. 1, 2018. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2017/064784, mailed Jun. 20, 2019. [cited by applicant]
International Search Report for PCT/US2017/48641, mailed Nov. 9, 2017. [cited by applicant]
International Preliminary Report on Patentability for Application No. PCT/US2017/48641 mailed Mar. 7, 2019. [cited by applicant]
International Search Report and Written Opinion for PCT/US2018/040488, mailed Oct. 15, 2018. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2018/040488, mailed Jan. 9, 2020. [cited by applicant]
International Search Report and Written Opinion for PCT/US2018/040494, mailed Oct. 10, 2018. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2018/040494, mailed Jan. 9, 2020. [cited by applicant]
Invitation to Pay Additional Fees for PCT/US2018/040496, mailed on Nov. 21, 2018. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2018/040496 mailed Jan. 14, 2019. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2018/040496, mailed Jan. 9, 2020. [cited by applicant]
Aguirre-Chagala et al., Phenylboronic Acid-Installed Polycarbonates for the ph-Dependent Release of Diol-Containing Molecules. ACS Macro Letters. Nov. 20, 2014;3(12):1249-1253. [cited by applicant]
Ahn et al., Two-photon fluorescence microscopy imaging of cellular oxidative stress using profluorescent nitroxides. J Am Chem Soc. Mar. 14, 2012;134(10):4721-30. doi: 10.1021/ja210315x. Epub Mar. 1, 2012. [cited by applicant]
Aime et al., Lanthanide(III) chelates for NMR biomedical applications. Chem. Soc. Rev., 1998;27:19-29. [cited by applicant]
Aime et al., Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. Acc Chem Res. Jul. 21, 2009;42(7):822-31. doi: 10.1021/ar800192p. [cited by applicant]
Alge et al., Synthetically tractable click hydrogels for three-dimensional cell culture formed using tetrazine-norbornene chemistry. Biomacromolecules. Apr. 8, 2013;14(4):949-53. doi: 10.1021/bm4000508. Epub Mar. 8, 201… [cited by applicant]
Altintas et al., Constructing star polymersvia modular ligation strategies. Polym. Chem., 2012;3:34-45. DOI: 10.1039/C1PY00249J. [cited by applicant]
Alvaradejo et al., Polyoxazoline-Based Bottlebrush and Brush-Arm Star Polymers via ROMP: Syntheses and Applications as Organic Radical Contrast Agents. ACS Macro Lett. Apr. 16, 2019;8(4):473-478. doi: 10.1021/acsmacrole… [cited by applicant]
Amouri et al., Host-guest interactions: design strategy and structure of an unusual cobalt cage that encapsulates a tetrafluoroborate anion. Angew Chem Int Ed Engl. Jul. 18, 2005;44(29):4543-6. [cited by applicant]
Anderson, Late Transition Metal Complexes of Pentafluorophenylphosphino-Pincer Ligands. Doctoral Thesis. Victoria University of Wellington. 2012:ii, iii, 32. [cited by applicant]
Angelov et al., EPR and rheological study of hybrid interfaces in gold-clay-epoxy nanocomposites. Langmuir. Nov. 11, 2014;30(44):13411-21. doi: 10.1021/la503361k. Epub Oct. 30, 2014. [cited by applicant]
Angot et al., Living Radical Polymerization Immobilized on Wang Resins: Synthesis and Harvest of Narrow Polydispersity Poly(methacrylate)s. Macromolecules, 2001;34(4):768-774. DOI: 10.1021/ma0011690. [cited by applicant]
Anraku et al., Size-controlled long-circulating PICsome as a ruler to measure critical cut-off disposition size into normal and tumor tissues. Chem Commun (Camb). Jun. 7, 2011;47(21):6054-6. doi: 10.1039/c1cc11465d. Epu… [cited by applicant]
Arvizo et al., Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles. PLoS One. 2011;6(9):e24374. doi: 10.1371/journal.pone.0024374. Epub Sep. 13, 2011. [cited by applicant]
Aryal et al., Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. Mol Pharm. Aug. 1, 2011;8(4):1401-7. doi: 10.1021/mp200243k. Epub Jul. 6, 2011. [cited by applicant]
Bapat et al., Dynamic-covalent nanostructures prepared by Diels-Alder reactions of styrene-maleic anhydride-derived copolymers obtained by one-step cascade block copolymerization. Polym. Chem., 2012;3:3112-3120. DOI: 10… [cited by applicant]
Bapat et al., Redox-Responsive Dynamic-Covalent Assemblies: Stars and Miktoarm Stars. Macromolecules, 2013;46(6):2188-2198. DOI: 10.1021/ma400169m. [cited by applicant]
Barbour et al., An intermolecular (H2O)10 cluster in a solid-state supramolecular complex. Nature. 1998;393(6686): 671-673. [cited by applicant]
Barner et al., Synthesis of core-shell poly(divinylbenzene) microspheres via reversible addition fragmentation chain transfer graft polymerization of styrene. J. Polym. Sci. A Polym. Chem., 42: 5067-5076. doi:10.1002/po… [cited by applicant]
Barnes et al., Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity. J Am Chem Soc. Sep. 28, 2016;138(38):12494-501. doi:… [cited by applicant]
Barrett et al., pH-Based Regulation of Hydrogel Mechanical Properties Through Mussel-Inspired Chemistry and Processing. Advanced Functional Materials. Mar. 6, 2013;23(9):1111-1119. [cited by applicant]
Bar-Shir et al., Single 19F Probe for Simultaneous Detection of Multiple Metal Ions Using miCEST MRI. J. Am. Chem. Soc., 2015;137(1):78-81. DOI: 10.1021/ja511313k. [cited by applicant]
Bates et al., Polarity-switching top coats enable orientation of sub-10-nm block copolymer domains. Science. Nov. 9, 2012;338(6108):775-9. doi: 10.1126/science.1226046. [cited by applicant]
Beck et al., Multistimuli, multiresponsive metallo-supramolecular polymers. J Am Chem Soc. Nov. 19, 2003;125(46):13922-3. [cited by applicant]
Bender et al., Site-isolated luminescent europium complexes with polyester macroligands: metal-centered heteroarm stars and nanoscale assemblies with labile block junctions. J Am Chem Soc. Jul. 24, 2002;124(29):8526-7. [cited by applicant]
Blencowe et al., Core cross-linked star polymers via controlled radical polymerisation. Polymer Jan. 2009;50(1):5-32. [cited by applicant]
Blinco et al., Profluorescent Nitroxides as Sensitive Probes of Oxidative Change and Free Radical Reactions. Australian Journal of Chemistry 2010;64(4):373-389. https://doi.org/10.1071/CH10442. [cited by applicant]
Boase et al., Molecular imaging with polymers. Polym. Chem., 2012,3, 1384-1389. DOI: 10.1039/C2PY20132A. [cited by applicant]
Bobko et al., Reversible reduction of nitroxides to hydroxylamines: roles for ascorbate and glutathione. Free Radic Biol Med. Feb. 1, 2007;42(3):404-12. Epub Nov. 10, 2006. [cited by applicant]
Bohbot-Raviv et al., Discovering new ordered phases of block copolymers. Phys Rev Lett. Oct. 16, 2000;85(16):3428. [cited by applicant]
Bolton et al., Synthesis and Melt Self-Assembly of PS-PMMA-PLA Triblock Bottlebrush Copolymers. Macromolecules, 2014;47(9):2864-74. DOI: 10.1021/ma500625k. [cited by applicant]
Brasch et al., Work in progress: nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals. Radiology. Jun. 1983;147(3):773-9. [cited by applicant]
Brasch, Work in progress: methods of contrast enhancement for NMR imaging and potential applications. A subject review. Radiology. Jun. 1983;147(3):781-8. [cited by applicant]
Brummelhuis et al., Stimuli-responsive star polymers through thiol-yne core functionalization/crosslinking of block copolymer micelles. Polym. Chem., 2011;2:1180-1184. DOI: 10.1039/C1PY00002K. [cited by applicant]
Budil et al., Nonlinear-Least-Squares Analysis of Slow-Motion EPR Spectra in One and Two Dimensions Using a Modified Levenberg-Marquardt Algorithm. Elsevier. Journal of Magnetic Resonance, Series A. Jun. 1996;120(2):155… [cited by applicant]
Buerkle et al., Supramolecular gels formed from multi-component low molecular weight species. Chem Soc Rev. Sep. 21, 2012;41(18):6089-102. doi: 10.1039/c2cs35106d. Epub Jun. 7, 2012. [cited by applicant]
Bunzen et al., Self-assembly of M24L48 polyhedra based on empirical prediction. Angew Chem Int Ed Engl. Mar. 26, 2012;51(13):3161-3. doi: 10.1002/anie.201108731. [cited by applicant]
Burdynska et al., Synthesis of Star Polymers Using ARGET ATRP. Macromolecules, 2010;43(22):9227-9229. DOI: 10.1021/ma101971z. [cited by applicant]
Burnworth et al., Decoupling Optical Properties in Metallo-Supramolecular Poly (p-phenylene ethynylene)s. Macromolecules. 2008;41(6):2157-2163. [cited by applicant]
Burts et al., Brush-first and click: efficient synthesis of nanoparticles that degrade and release doxorubicin in response to light. Photochem Photobiol. Mar.-Apr. 2014;90(2):380-5. doi: 10.1111/php.12182. Epub Nov. 25,… [cited by applicant]
Burts et al., Brush-first synthesis of core-photodegradable miktoarm star polymers via ROMP: towards photoresponsive self-assemblies. Macromol Rapid Commun. Jan. 2014;35(2):168-173. doi: 10.1002/marc.201300618. Epub Nov… [cited by applicant]
Burts et al., Using EPR To Compare PEG-branch-nitroxide “Bivalent-Brush Polymers” and Traditional PEG Bottle-Brush Polymers: Branching Makes a Difference. Macromolecules. 2012;45(20):8310-18. [cited by applicant]
Cabral et al., Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol. Oct. 23, 2011;6(12):815-23. doi: 10.1038/nnano.2011.166. [cited by applicant]
Caiolfa et al., Polymer-bound camptothecin: initial biodistribution and antitumour activity studies. J Control Release. Mar. 1, 2000;65(1-2):105-19. [cited by applicant]
Campos-Fernández et al., A One-Pot, High-Yield Synthesis of a Paramagnetic Nickel Square from Divergent Precursors by Anion Template Assembly. Angewandte Chemie International Edition. Dec. 3, 1999;38(23):3477-3479. [cited by applicant]
Campos-Fernández et al., Fine-tuning the ring-size of metallacyclophanes: a rational approach to molecular pentagons. J Am Chem Soc. Jan. 31, 2001;123(4):773-4. [cited by applicant]
Caravan et al., Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. Chem Rev. Sep. 8, 1999;99(9):2293-352. [cited by applicant]
Castilla et al., Stereochemistry in subcomponent self-assembly. Acc Chem Res. Jul. 15, 2014;47(7):2063-73. doi: 10.1021/ar5000924. Epub May 2, 2014. [cited by applicant]
Chambron et al., Topologically complex molecules obtained by transition metal templation: it is the presentation that determines the synthesis strategy. New Journal of Chemistry. 2013;37(1):49-57. [cited by applicant]
Chand et al., Self-assembly of a novel macrotricyclic Pd(II) metallocage encapsulating a nitrate ion. Chem Commun (Camb). Sep. 7, 2001;(17):1652-3. [cited by applicant]
Chang et al., Dose-dense chemotherapy improves mechanisms of antitumor immune response. Cancer Res. Jan. 1, 2013;73(1):119-27. doi: 10.1158/0008-5472.CAN-12-2225. Epub Oct. 29, 2012. [cited by applicant]
Chen et al., Polymeric phosphorylcholine-camptothecin conjugates prepared by controlled free radical polymerization and click chemistry. Bioconjug Chem. Dec. 2009;20(12):2331-41. doi: 10.1021/bc900339x. [cited by applicant]
Chen et al., Synthesis of superporous hydrogels: hydrogels with fast swelling and superabsorbent properties. J Biomed Mater Res. Jan. 1999;44(1):53-62. [cited by applicant]
Cheng et al., Well-defined diblock macromonomer with a norbornene group at block junction: anionic living linking synthesis and ring-opening metathesis polymerization. Macromol. Mar. 4, 2010;43(7):3153-5. [cited by applicant]
Cheon et al., Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology.Acc Chem Res. Dec. 2008;41(12):1630-40. doi: 10.1021/ar800045c. [cited by applicant]
Chiang et al., Vitamin D for the prevention and treatment of pancreatic cancer. World J Gastroenterol. Jul. 21, 2009;15(27):3349-54. [cited by applicant]
Chifotides et al., Anion-π interactions in supramolecular architectures. Acc Chem Res. Apr. 16, 2013;46(4):894-906. doi: 10.1021/ar300251k. Epub Mar. 11, 2013. [cited by applicant]
Choi et al., Self-confirming “And” logic nanoparticles for fault-free MRI. J Am Chem Soc. Aug. 18, 2010;132(32):11015-7. doi: 10.1021/ja104503g. [cited by applicant]
Chou et al., In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging. J Am Chem Soc. Sep. 29, 2010;132(38):13270-8. doi: 10.1021/ja1035013. [cited by applicant]
Clever et al., Inclusion of anionic guests inside a molecular cage with palladium(II) centers as electrostatic anchors. Angew Chem Int Ed Engl. 2009;48(38):7010-2. doi: 10.1002/anie.200902717. [cited by applicant]
Cok et al., Synthesis of Model Network Hydrogels via Tetrazine-Olefin Inverse Electron Demand Diels-Alder Cycloaddition. Macromolecular Symposia. Jul. 2013;329(1):108-112. [cited by applicant]
Conrad et al., Tunable, temperature-responsive polynorbornenes with side chains based on an elastin peptide sequence. Angew Chem Int Ed Engl. 2009;48(44):8328-30. doi: 10.1002/anie.200903888. [cited by applicant]
Cordier et al., Self-healing and thermoreversible rubber from supramolecular assembly. Nature. Feb. 21, 2008;451(7181):977-80. doi: 10.1038/nature06669. [cited by applicant]
Dag et al., Three-arm star ring opening metathesis polymers via alkyne-azide click reaction. J. Polym. Sci. A Polym. Chem., 47: 2344-2351. doi:10.1002/pola.23324. [cited by applicant]
Dalsin et al., Bottlebrush block polymers: Quantitative theory and experiments. ACS Nano. Nov. 6, 2015;9(12):12233-45. [cited by applicant]
Davies et al., Environmentally responsive MRI contrast agents. Chem Commun (Camb). Oct. 28, 2013;49(84):9704-21. doi: 10.1039/c3cc44268c. [cited by applicant]
Davis et al., A novel nitroxide is an effective brain redox imaging contrast agent and in vivo radioprotector. Free Radic Biol Med. Aug. 1, 2011;51(3):780-90. doi: 10.1016/j.freeradbiomed.2011.05.019. Epub May 25, 2011. [cited by applicant]
Davis et al., Atom transfer radical polymerization of tert-butyl acrylate and preparation of block copolymers. Macromol. May 30, 2000;33(11):4039-47. [cited by applicant]
Davis et al., Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. Sep. 2008;7(9):771-82. doi: 10.1038/nrd2614. [cited by applicant]
Desmarets et al., Design, Self-Assembly, and Molecular Structures of 3D Copper(II) Capsules Templated by BF4-Guest Anions. European Journal of Inorganic Chemistry. Oct. 2009;(29-30):4396-4400. doi: 10.1002/ejic.20090060… [cited by applicant]
Detappe et al., Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy. J Control Release. Sep. 28, 2016;238:103-113. doi: 10.1016/j.jconrel.2016.07.021. Epub Jul. 14, 2016. [cited by applicant]
Dhar et al., Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads. J Am Chem Soc. Oct. 21, 2009;131(41):14652-3. doi: 10.1021/ja9071282. [cited by applicant]
Dhar et al., Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proc Natl Acad Sci U S A. Feb. 1, 2011;108(5):1850-5. doi: 10.1073/pnas.1011379108. Epub Jan. 13, 2011. [cited by applicant]
Dhar et al., Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci U S A. Nov. 11, 2008;105(45):17356-61. doi: 10.1073/pnas.080915410… [cited by applicant]
Doane et al., The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem Soc Rev. Apr. 7, 2012;41(7):2885-911. doi: 10.1039/c2cs15260f. Epub Jan. 27, 2012. [cited by applicant]
Duncan, The dawning era of polymer therapeutics. Nat Rev Drug Discov. May 2003;2(5):347-60. [cited by applicant]
Durr et al., Mild and Efficient Modular Synthesis of Poly(acrylonitrile-co-butadiene) Block and Miktoarm Star Copolymer Architectures. Macromolecules, 2013;46(1):49-62. DOI: 10.1021/ma302017c. [cited by applicant]
Elliott et al., Metabolism of brain tissue slices and suspensions from various mammals. J Neurophysiol. Nov. 1948;11(6):473-84. [cited by applicant]
Eryazici et al., Two Large-Pore Metal-Organic Frameworks Derived from a Single Polytopic Strut. Crystal Growth & Design. Mar. 7, 2012;12(3):1075-1080. [cited by applicant]
Feng et al., A metabonomic analysis of organ specific response to USPIO administration. Biomaterials. Sep. 2011;32(27):6558-69. doi: 10.1016/j.biomaterials.2011.05.035. [cited by applicant]
Fenlon et al., The Thread & Cut Method: Syntheses of Molecular Knot Precursors. Eur J Org Chem. Jun. 2008;2008(18):3065-3068. [cited by applicant]
Ferrauto et al., Frequency-encoded MRI-CEST agents based on paramagnetic liposomes/RBC aggregates. Nano Lett. Dec. 10, 2014;14(12):6857-62. doi: 10.1021/nl5026612. Epub Nov. 10, 2014. [cited by applicant]
Ferrauto et al., Lanthanide-loaded erythrocytes as highly sensitive chemical exchange saturation transfer MRI contrast agents. J Am Chem Soc. Jan. 15, 2014;136(2):638-41. doi: 10.1021/ja411793u. Epub Dec. 30, 2013. [cited by applicant]
Forgan et al., Chemical topology: complex molecular knots, links, and entanglements. Chem Rev. Sep. 14, 2011;111(9):5434-64. doi: 10.1021/cr200034u. Epub Jun. 21, 2011. [cited by applicant]
Foster et al., Differentially Addressable Cavities within Metal-Organic Cage-Cross-Linked Polymeric Hydrogels. J Am Chem Soc. Aug. 5, 2015;137(30):9722-9. doi: 10.1021/jacs.5b05507. Epub Jul. 23, 2015. [cited by applicant]
Fox et al., Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res. Aug. 18, 2009;42(8):1141-51. doi: 10.1021/ar900035f. [cited by applicant]
Frechet. Functional polymers and dendrimers: reactivity, molecular architecture, and interfacial energy. Science. Mar. 25, 1994;263(5154):1710-5. [cited by applicant]
Fullenkamp et al., Mussel-Inspired Histidine-Based Transient Network Metal Coordination Hydrogels. Macromolecules. Jan. 18, 2013;46(3):1167-1174. [cited by applicant]
Gao et al., Development of star polymers as unimolecular containers for nanomaterials. Macromol Rapid Commun. May 14, 2012;33(9):722-34. doi: 10.1002/marc.201200005. Epub Mar. 14, 2012. [cited by applicant]
Gao et al., Modular Approaches to Star and Miktoarm Star Polymers by ATRP of Cross-Linkers. Macromol. Symp., 291-292: 12-16. doi: 10.1002/masy.201050502. [cited by applicant]
Gao et al., Synthesis of Acid-Labile PEG and PEG-Doxorubicin-Conjugate Nanoparticles via Brush-First ROMP. ACS Macro Lett. Sep. 16, 2014;3(9):854-857. Epub Aug. 13, 2014. [cited by applicant]
Gao et al., Synthesis of functional polymers with controlled architecture by CRP of monomers in the presence of cross-linkers: From stars to gels. Progress in Polymer Science Apr. 2009;34(4):317-350. [cited by applicant]
Gao et al., Synthesis of Star Polymers by A New “Core-First” Method: Sequential Polymerization of Cross-Linker and Monomer. Macromolecules, 2008;41(4):1118-1125. [cited by applicant]
Ge et al., A Pyrene-functionalized Polynorbornene for Ratiometric Fluorescence Sensing of Pyrophosphate. Chem. Asian J. 2016;11:687. [cited by applicant]
Gestwicki et al., Influencing receptor-ligand binding mechanisms with multivalent ligand architecture. J Am Chem Soc. Dec. 18, 2002;124(50):14922-33. [cited by applicant]
Gilgorich et al., Palladium-catalyzed reductive coupling of styrenes and organostannanes under aerobic conditions. J Am Chem Soc. Nov. 21, 2007;129(46):14193-5. Epub Oct. 27, 2007. [cited by applicant]
Glunde et al., Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer. Chem Rev. May 12, 2010;110(5):3043-59. doi: 10.1021/cr9004007. [cited by applicant]
Godugu et al., Abstract 2139: Effect of telmisartan on triple negative breast cancer (TNBC) and lung cancer tumor progression and intratumoral distribution of nanoparticles. Cancer Res. 2013;73(8). [cited by applicant]
Goh et al., Highly efficient synthesis of low polydispersity core cross-linked star polymers by Ru-catalyzed living radical polymerization. Macromol Rapid Commun. Mar. 2, 2011;32(5):456-61. doi: 10.1002/marc.201000641. … [cited by applicant]
Grahovac et al., Abstract B41: The angiotensin receptor blocker telmisartan inhibits the growth of pancreatic ductal adenocarcinoma and improves survival. Cancer Res. 2016;76(24). [cited by applicant]
Grason et al., Geometric theory of diblock copolymer phases. Phys Rev Lett. Jul. 31, 2003;91(5):058304. [cited by applicant]
Greenwald et al., Effective drug delivery by PEGylated drug conjugates. Adv Drug Deliv Rev. Feb. 10, 2003;55(2):217-50. [cited by applicant]
Gumbley et al., Photoresponsive Polymers Containing Nitrobenzyl Esters via Ring-Opening Metathesis Polymerization. Macromolecules. 2011;44(20):7956-61. [cited by applicant]
Hackelbusch et al., Chain Dynamics in Supramolecular Polymer Networks. Macromolecules. 2013;46(15):6273-6286. [cited by applicant]
Hackelbusch et al., Multiresponsive Polymer Hydrogels by Orthogonal Supramolecular Chain Cross-Linking. Macromolecules. 2014;47(12):4028-4036. [cited by applicant]
Haddleton et al., Well-defined oligosaccharide-terminated polymers from living radical polymerization. Biomacromolecules. 2000 Summer;1(2):152-6. [cited by applicant]
Hafkamp et al., Organogel formation and molecular imprinting by functionalized gluconamides and their metal complexes. Chemical Communications. 1997;6:545-546. doi: 10.1039/A608266A. [cited by applicant]
Hall et al., Platinum(IV) antitumour compounds: their bioinorganic chemistry. Coord Chem Rev. 2002;232:49-67. [cited by applicant]
Hall et al., The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cells. J Biol Inorg Chem. Sep. 2003;8(7):726-32. Epub Jul. 12, 2003. [cited by applicant]
Han et al., Recent Development of Peptide Coupling Reagents in Organic Synthesis. Tetrahedron, 2004;60:2447-2467. [cited by applicant]
Hansell et al., Additive-free clicking for polymer functionalization and coupling by tetrazine-norbornene chemistry. J Am Chem Soc. Sep. 7, 2011;133(35):13828-31. doi: 10.1021/ja203957h. Epub Aug. 11, 2011. [cited by applicant]
Hao et al., Dendrimers as scaffolds for multifunctional reversible addition—fragmentation chain transfer agents: Syntheses and polymerization. J. Polym. Sci. A Polym. Chem., 2004;42:5877-5890. doi:10.1002/pola.20434. [cited by applicant]
Harrington et al., Holdfast heroics: comparing the molecular and mechanical properties of Mytilus californianus byssal threads. J Exp Biol. Dec. 2007;210(Pt 24):4307-18. [cited by applicant]
Harrington et al., Iron-clad fibers: a metal-based biological strategy for hard flexible coatings. Science. Apr. 9, 2010;328(5975):216-20. doi: 10.1126/science.1181044. Epub Mar. 4, 2010. [cited by applicant]
Harris et al., Giant hollow M(n)L(2n) spherical complexes: structure, functionalisation and applications. Chem Commun (Camb). Aug. 4, 2013;49(60):6703-12. doi: 10.1039/c3cc43191f. [cited by applicant]
Harrison et al., A multimeric MR-optical contrast agent for multimodal imaging. Chem Commun (Camb). Oct. 9, 2014;50(78):11469-71. doi: 10.1039/c4cc05651e. [cited by applicant]
Harrison et al., Multimeric Near IR-MR Contrast Agent for Multimodal In Vivo Imaging. J Am Chem Soc. Jul. 22, 2015;137(28):9108-16. doi: 10.1021/jacs.5b04509. Epub Jul. 14, 2015. [cited by applicant]
Harvey et al., Lanthanide Complexes as Paramagnetic Probes for 19F Magnetic Resonance. Eur. J. Inorg. Chem., 2012: 2015-2022. doi:10.1002/ejic.201100894. [cited by applicant]
Hatje et al., Increases in Anthropogenic Gadolinium Anomalies and Rare Earth Element Concentrations in San Francisco Bay over a 20 Year Record. Environ Sci Technol. Apr. 19, 2016;50(8):4159-68. doi: 10.1021/acs.est.5b04… [cited by applicant]
Hawker et al., Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules. J Am Chem Soc. Oct. 1990;112(21):7638-47. [cited by applicant]
Hedrick et al., Dendrimer-like Star Block and Amphiphilic Copolymers by Combination of Ring Opening and Atom Transfer Radical Polymerization. Macromolecules, 1998;31(25):8691-8705. DOI: 10.1021/ma980932b. [cited by applicant]
Hein et al., Copper-catalyzed azide-alkyne cycloaddition (CuAAC) and beyond: new reactivity of copper(I) acetylides. Chem Soc Rev. Apr. 2010;39(4):1302-15. doi: 10.1039/b904091a. Epub Mar. 4, 2010. [cited by applicant]
Helms et al., One-Pot Reaction Cascades Using Star Polymers with Core-Confined Catalysts. Angewandte Chemie, 2005;44:6384-6387. doi:10.1002/ange.200502095. [cited by applicant]
Heroguez et al., Novel Styrene—Butadiene Copolymers by Ring-Opening Metathesis Polymerization. Macromol. Oct. 3, 2000;33(20):7241-8. [cited by applicant]
Hirakawa et al., Removal of Perchlorate Anion from an Aqueous Solution by Encapsulation in an Anion-templated Self-assembled Molecular Capsule. Chemistry Letters. 2009;38(3):290-291. [cited by applicant]
Holbrook et al., Gd(III)-Dithiolane Gold Nanoparticles for T1-Weighted Magnetic Resonance Imaging of the Pancreas. Nano Lett. May 11, 2016;16(5):3202-9. doi: 10.1021/acs.nanolett.6b00599. Epub Apr. 20, 2016. [cited by applicant]
Holliday et al., Strategies for the Construction of Supramolecular Compounds through Coordination Chemistry. Angew Chem Int Ed Engl. Jun. 1, 2001;40(11):2022-2043. [cited by applicant]
Holten-Andersen et al., Metal-coordination: using one of nature's tricks to control soft material mechanics. J. Mater. Chem. B. 2014;2:2467-2472. [cited by applicant]
Holten-Andersen et al., pH-induced metal-ligand cross-links inspired by mussel yield self-healing polymer networks with near-covalent elastic moduli. PNAS. Feb. 15, 2011;108:2651-2655. [cited by applicant]
Hoogenboom et al., 1-Lactide Polymerization Utilizing a Hydroxy-Functionalized 3,6-Bis(2-pyridyl)pyridazine as Supramolecular (Co)initiator: Construction of Polymeric [2 ×2] Grids. Macromolecules, 2003;36(13):4743-9. DO… [cited by applicant]
Hu et al., Enhancing Gelation of Doubly Thermosensitive Hydrophilic ABC Linear Triblock Copolymers in Water by Thermoresponsive Hairy Nanoparticles. Macromolecules, 2016;49(15):5502-13. DOI: 10.1021/acs.macromol.6b01156. [cited by applicant]
Hu et al., Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem Pharmacol. Apr. 15, 2012;83(8):1104-11. doi: 10.1016/j.bcp.2012.01.008. Epub Jan. 18, 2012. [cited by applicant]
Huang et al., Polymer-Stabilized Perfluorobutane Nanodroplets for Ultrasound Imaging Agents. J Am Chem Soc. Jan. 11, 2017;139(1):15-18. doi: 10.1021/jacs.6b08800. Epub Dec. 29, 2016. [cited by applicant]
Huinink et al., Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. J Clin Oncol. Jun. 1997;15(6):2183-93. [cited by applicant]
Huynh, Novel Polymeric Micelles via RAFT Polymerization for Platinum Drug Delivery. Doctoral Thesis. The University of New South Wales. 2012. [cited by applicant]
Hyodo et al., Assessment of tissue redox status using metabolic responsive contrast agents and magnetic resonance imaging. J Pharm Pharmacol. Aug. 2008;60(8):1049-60. doi: 10.1211/jpp.60.8.0011. [cited by applicant]
Hyodo et al., Brain redox imaging using blood-brain barrier-permeable nitroxide MRI contrast agent. J Cereb Blood Flow Metab. Jun. 2008;28(6):1165-74. doi: 10.1038/jcbfm.2008.5. Epub Feb. 13, 2008. [cited by applicant]
Hyodo et al., Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents. Cancer Res. Oct. 15, 2006;66(20):9921-8. [cited by applicant]
Iha et al., Applications of Orthogonal “Click” Chemistries in the Synthesis of Functional Soft Materials. Chem. Rev., 2009;109(11):5620-5686. DOI: 10.1021/cr900138t. [cited by applicant]
Inglis et al., Well-defined star shaped polymer-fullerene hybrids via click chemistry. Soft Matter, 2010;6:82-84. DOI: 10.1039/B920806M. [cited by applicant]
Jackson et al., pH triggered self-assembly of core cross-linked star polymers possessing thermoresponsive cores. Chem. Commun., 2011;47:6807-6809. DOI: 10.1039/C1CC11785H. [cited by applicant]
Jakubowski et al., Activators regenerated by electron transfer for atom transfer radical polymerization of styrene. Macromol. Jan. 10, 2006;39(1):39-45. [cited by applicant]
Jamieson et al., Structure, Recognition, and Processing of Cisplatin-DNA Adducts. Chem Rev. Sep. 8, 1999;99(9):2467-98. [cited by applicant]
Jeong et al., Highly tunable self-assembled nanostructures from a poly (2-vinylpyridine-b-dimethylsiloxane) block copolymer. Nano Lett. Sep. 27, 2011;11(10):4095-101. [cited by applicant]
Jesberger et al., Hyperbranched polymers as scaffolds for multifunctional reversible addition—fragmentation chain-transfer agents: A route to polystyrene-core-polyesters and polystyrene-block-poly(butyl acrylate)-core-p… [cited by applicant]
Jiang et al., Morphology and Phase Diagram of Comb Block Copolymer A m+ 1 (BC) m. J Phys Chem B. May 7, 2009;113(21):7462-7. [cited by applicant]
Johnson et al., Core-clickable PEG-branch-azide bivalent-bottle-brush polymers by ROMP: grafting-through and clicking-to. J Am Chem Soc. Jan. 26, 2011;133(3):559-66. doi: 10.1021/ja108441d. Epub Dec. 13, 2010. [cited by applicant]
Johnson et al., Drug-loaded, bivalent-bottle-brush polymers by graft-through ROMP. Macromolecules. Dec. 28, 2010;43(24):10326-10335. [cited by applicant]
Johnson et al., Efficient Synthesis of Doxorubicin Releasing Brush Polymers by Graft-Through Romp. Polymer Preprints. 2010;51(2):96-97. [cited by applicant]
Jokerst et al., Molecular imaging with theranostic nanoparticles. Acc Chem Res. Oct. 18, 2011;44(10):1050-60. doi: 10.1021/ar200106e. Epub Sep. 15, 2011. [cited by applicant]
Jokerst et al., Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond). Jun. 2011;6(4):715-28. doi: 10.2217/nnm.11.19. [cited by applicant]
Joralemon et al., PEGylated polymers for medicine: from conjugation to self-assembled systems. Chem Commun (Camb). Mar. 7, 2010;46(9):1377-93. doi: 10.1039/b920570p. Epub Jan. 28, 2010. [cited by applicant]
Jung et al., Orientation-controlled self-assembled nanolithography using a polystyrene—polydimethylsiloxane block copolymer. Nano Lett. Jul. 11, 2007;7(7):2046-50. [cited by applicant]
Kale et al., Supramolecular assemblies of amphiphilic homopolymers. Langmuir. May 19, 2009;25(17):9660-70. [cited by applicant]
Kalyani et al., Oxidatively intercepting Heck intermediates: Pd-catalyzed 1,2- and 1,1-arylhalogenation of alkenes. J Am Chem Soc. Feb. 20, 2008;130(7):2150-1. doi: 10.1021/ja0782798. Epub Jan. 30, 2008. [cited by applicant]
Kauffman et al., Fluorescence-Based Assays for Measuring oxorubicin in Biological Systems. React Oxyg Species (Apex). 2016;2(6):432-439. doi: 10.20455/ros.2016.873. PMID: 29707647; PMCID: PMC5921830. [cited by applicant]
Kawamoto et al., Graft-through Synthesis and Assembly of Janus Bottlebrush Polymers from A-Branch-B Diblock Macromonomers. J Am Chem Soc. Sep. 14, 2016;138(36):11501-4. doi: 10.1021/jacs.6b07670. Epub Sep. 1, 2016. [cited by applicant]
Kawamoto et al., Loops versus branch functionality in model click hydrogels. Macromol. Dec. 1, 2015;48(24):8980-8. [cited by applicant]
Kean et al., Increasing the maximum achievable strain of a covalent polymer gel through the addition of mechanically invisible cross-links. Adv Mater. Sep. 10, 2014;26(34):6013-8. doi: 10.1002/adma.201401570. Epub Jul. … [cited by applicant]
Keana et al., Nitroxides as potential contrast enhancing agents for MRI application: influence of structure on the rate of reduction by rat hepatocytes, whole liver homogenate, subcellular fractions, and ascorbate. Magn… [cited by applicant]
Khanna et al., Designing Miktoarm Polymers Using a Combination of “Click” Reactions in Sequence with Ring-Opening Polymerization. Macromolecules, 2010;43(13):5688-5698. DOI: 10.1021/ma100845a. [cited by applicant]
Kim et al., Anion-directed self-assembly of coordination polymer into tunable secondary structure. J Am Chem Soc. Jun. 9, 2004;126(22):7009-14. [cited by applicant]
Kirchhoff et al., Boronic acids: new coupling partners in room-temperature Suzuki reactions of alkyl bromides. Crystallographic characterization of an oxidative-addition adduct generated under remarkably mild conditions… [cited by applicant]
Kishi et al., An M2L4 molecular capsule with an anthracene shell: encapsulation of large guests up to 1 nm. J Am Chem Soc. Aug. 3, 2011;133(30):11438-41. doi: 10.1021/ja2037029. Epub Jul. 8, 2011. [cited by applicant]
Kokuryo et al., SPIO-PICsome: development of a highly sensitive and stealth-capable MRI nano-agent for tumor detection using SPIO-loaded unilamellar polyion complex vesicles (PICsomes). J Control Release. Aug. 10, 2013;… [cited by applicant]
Kolishetti et al., Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci U S A. Oct. 19, 2010;107(42):17939-44. doi: 10.1073/pnas.1011368107. Epub Oct.… [cited by applicant]
Kreutzer et al., Water-Soluble, Unimolecular Containers Based on Amphiphilic Multiarm Star Block Copolymers. Macromolecules, 2006;39(13):4507-4516. DOI: 10.1021/ma060548b. [cited by applicant]
Kwon et al., Block copolymer micelles as long-circulating drug vehicles. Adv Drug Delivery Rev. 1995;16:295-309. [cited by applicant]
Lammers et al., Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers. Biomaterials. Jul. 2009;30(20):3466-75. doi: 10.1016/j.biomaterials.2009.02.040. Epub Mar.… [cited by applicant]
Lee et al., Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev. Apr. 7, 2012;41(7):2656-72. doi: 10.1039/c2cs15261d. Epub Dec. 21, 2011. [cited by applicant]
Lee et al., Mussel-Inspired Adhesives and Coatings. Annu Rev Mater Res. Aug. 1, 2011;41:99-132. [cited by applicant]
Lee et al., Novel phase morphologies in a microphase-separated dendritic polymer melt. Macromol. Jan. 12, 2009;42(3):849-59. [cited by applicant]
Lee et al., Single-molecule mechanics of mussel adhesion. Proc Natl Acad Sci U S A. Aug. 29, 2006;103(35):12999-3003. Epub Aug. 18, 2006. [cited by applicant]
Lee et al., Stimuli-responsive molecular brushes. Progress in Polymer Science (Oxford), 35(1-2), 24-44. DOI: 10.1016/j.progpolymsci.2009.11.002. [cited by applicant]
Leininger et al., Self-assembly of discrete cyclic nanostructures mediated by transition metals. Chem Rev. Mar. 8, 2000;100(3):853-908. [cited by applicant]
Li et al., Polycatechol Nanoparticle MRI Contrast Agents. Small, 2016;12(5):668-677. https://doi.org/10.1002/smll.201502754. [cited by applicant]
Li et al., A magnetic switch for spin-catalyzed interconversion of nuclear spin isomers. J Am Chem Soc. Mar. 31, 2010;132(12):4042-3. doi: 10.1021/ja910282p. [cited by applicant]
Li et al., Crosslinking-induced morphology change of latex nanoparticles: A study of RAFT-mediated polymerization in aqueous dispersed media using amphiphilic double-brush copolymers as reactive surfactants. J Polym Sci… [cited by applicant]
Li et al., Distance-Dependent Paramagnet-Enhanced Nuclear Spin Relaxation of H2@C60 Derivatives Covalently Linked to a Nitroxide Radical. J. Phys. Chem. Lett., 2010;1(14):2135-2138. DOI: 10.1021/jz100645w. [cited by applicant]
Li et al., Dynamic cylindrical assembly of triblock copolymers by a hierarchical process of covalent and supramolecular interactions. J Am Chem Soc. Jan. 4, 2011;133(5):1228-31. [cited by applicant]
Li et al., Efficient synthesis of narrowly dispersed amphiphilic double-brush copolymers through the polymerization reaction of macromonomer micelle emulsifiers at the oil-water interface. Polym Chem. 2016;7(27):4476-85. [cited by applicant]
Li et al., Facile syntheses of cylindrical molecular brushes by a sequential RAFT and ROMP “grafting-through” methodology. J Polym Sci A Polym Chem. Oct. 15, 2009;47(20):5557-5563. [cited by applicant]
Li et al., Highly fluorescent M2L4 molecular capsules with anthracene shells. Chem Commun (Camb). Aug. 14, 2011;47(30):8605-7. doi: 10.1039/clcc12946e. Epub Jun. 28, 2011. [cited by applicant]
Li et al., Isostructural M2L4 molecular capsules with anthracene shells: synthesis, crystal structures, and fluorescent properties. Chemistry. Jul. 2, 2012;18(27):8358-65. doi: 10.1002/chem.201200155. Epub May 25, 2012. [cited by applicant]
Li et al., Pinpointing the extent of electronic delocalization in the Re(I)-to-tetrazine charge-separated excited state using time-resolved infrared spectroscopy. J Am Chem Soc. Aug. 26, 2009;131(33):11656-7. doi: 10.10… [cited by applicant]
Li et al., Star Polymers via Cross-Linking Amphiphilic Macroinitiators by AGET ATRP in Aqueous Media. J. Am. Chem. Soc., 2009;131(30):10378-10379. DOI: 10.1021/ja904204g. [cited by applicant]
Li et al., Surface Properties of Bottlebrush Polymer Thin Films. Macromolecules. 2012;45(17):7118-7127. [cited by applicant]
Li et al., Synthesis of Hetero-Grafted Amphiphilic Diblock Molecular Brushes and Their Self-Assembly in Aqueous Medium. Macromolecules. 2010;43(3):1182-1184. [cited by applicant]
Li et al., Well-defined amphiphilic double-brush copolymers and their performance as emulsion surfactants. Macromol. May 18, 2012;45(11):4623-9. [cited by applicant]
Liang et al., The copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) “click” reaction and its applications. An overview. Coordination Chemistry Reviews Dec. 2011;255(23-24):2933-2945. [cited by applicant]
Liao et al., A convergent synthetic platform for single-nanoparticle combination cancer therapy: ratiometric loading and controlled release of cisplatin, doxorubicin, and camptothecin. J Am Chem Soc. Apr. 23, 2014;136(1… [cited by applicant]
Liao et al., A palladium-catalyzed three-component cross-coupling of conjugated dienes or terminal alkenes with vinyl triflates and boronic acids. J Am Chem Soc. Apr. 20, 2011;133(15):5784-7. doi: 10.1021/ja201358b. Epu… [cited by applicant]
Liao et al., Palladium-catalyzed hydroarylation of 1,3-dienes with boronic esters via reductive formation of pi-allyl palladium intermediates under oxidative conditions. J Am Chem Soc. Aug. 4, 2010;132(30):10209-11. doi… [cited by applicant]
Liao et al., Two-component control of guest binding in a self-assembled cage molecule. Chem Commun (Camb). Jul. 21, 2010;46(27):4932-4. doi: 10.1039/c0cc00234h. Epub Jun. 2010. [cited by applicant]
Lim et al., Multiplexed imaging of therapeutic cells with multispectrally encoded magnetofluorescent nanocomposite emulsions. J Am Chem Soc. Dec. 2, 2009;131(47):17145-54. doi: 10.1021/ja904472z. [cited by applicant]
Liu et al., “Brush-first” method for the parallel synthesis of photocleavable, nitroxide-labeled poly(ethylene glycol) star polymers. J Am Chem Soc. Oct. 3, 2012;134(39):16337-44. doi: 10.1021/ja3067176. Epub Sep. 24, 2… [cited by applicant]